Role of microRNAs in islet beta-cell compensation and failure during diabetes

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Plaisance, Valérie ^a   Waeber, Gérard ^b   Regazzi, Romano ^b   Abderrahmani, Amar ^a  

^a UNIV LILLE   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MICRORNA;

CELL EXPANSION; CELL FATE; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; DIABETOGENESIS; EXPERIMENTAL THERAPY; GENE EXPRESSION; HUMAN; INSULIN RELEASE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PREGNANCY; PRIORITY JOURNAL; REVIEW; STEM CELL; ADULT STEM CELL; ALLOSTASIS; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS);

ADULT STEM CELLS; ALLOSTASIS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICRORNAS; OBESITY; PREDIABETIC STATE; PREGNANCY;

EID: 84897003161     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/618652     Document Type: Review

References (114)

1. Prentki M., Nolan C. J., Islet β cell failure in type 2 diabetes. The Journal of Clinical Investigation 2006 116 7 1802 1812 2-s2.0-33745863033 10.1172/JCI29103 (Pubitemid 44033300)
2. Weir G. C., Bonner-Weir S., Five of stages of evolving β -cell dysfunction during progression to diabetes. Diabetes 2004 53 supplement 3 S16 S21 2-s2.0-9444242665 10.2337/diabetes.53.suppl-3.S16 (Pubitemid 39564517)
3. Butler A. E., Janson J., Bonner-Weir S., Ritzel R., Rizza R. A., Butler P. C., β -cell deficit and increased β -cell apoptosis in humans with type 2 diabetes. Diabetes 2003 52 1 102 110 2-s2.0-0037219411 10.2337/diabetes.52.1.102 (Pubitemid 36042113)
4. Meier J. J., Breuer T. G. K., Bonadonna R. C., Tannapfel A., Uhl W., Schmidt W. E., Schrader H., Menge B. A., Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 2012 55 5 1346 1354 2-s2.0-84856104087 10.1007/s00125-012-2466-8
5. Meier J. J., Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 2008 51 5 703 713 2-s2.0-41849097354 10.1007/s00125-008-0936-9
6. Camastra S., Manco M., Mari A., Baldi S., Gastaldelli A., Greco A. V., Mingrone G., Ferrannini E., β -cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 2005 54 8 2382 2389 2-s2.0-23644457358 10.2337/diabetes.54.8.2382 (Pubitemid 41134266)
7. Donath M. Y., Ehses J. A., Maedler K., Schumann D. M., Ellingsgaard H., Eppler E., Reinecke M., Mechanisms of β -cell death in type 2 diabetes. Diabetes 2005 54 supplement 2 S108 S113 2-s2.0-33644747390 10.2337/diabetes.54. suppl-2.S108 (Pubitemid 43343338)
8. Rahier J., Guiot Y., Goebbels R. M., Sempoux C., Henquin J. C., Pancreatic β -cell mass in European subjects with type 2 diabetes. Diabetes, Obesity & Metabolism 2008 10 supplement 4 32 42 2-s2.0-53549093011 10.1111/j.1463-1326.2008.00969.x
9. Marselli L., Suleiman M., Masini M., Campani D., Bugliani M., Syed F., Martino L., Focosi D., Scatena F., Olimpico F., Are we overestimating the loss of beta cells in type 2 diabetes? Diabetologia 2014 57 2 362 365 10.1007/s00125-013-3098-3
10. Gargani S., Thevenet J., Yuan J. E., Lefebvre B., Delalleau N., Gmyr V., Hubert T., Duhamel A., Pattou F., Kerr-Conte J., Adaptive changes of human islets to an obesogenic environment in the mouse. Diabetologia 2013 56 2 350 358 10.1007/s00125-012-2775-y
11. Tyrberg B., Ustinov J., Otonkoski T., Andersson A., Stimulated endocrine cell proliferation and differentiation in transplanted human pancreatic islets: effects of the ob gene and compensatory growth of the implantation organ. Diabetes 2001 50 2 301 307 2-s2.0-0035143062 (Pubitemid 32127286)
12. Maedler K., Donath M. Y., Beta-cells in type 2 diabetes: a loss of function and mass. Hormone Research 2004 62 supplement 3 67 73 2-s2.0-20444363538
13. Maedler K., Schumann D. M., Schulthess F., Oberholzer J., Bosco D., Berney T., Donath M. Y., Aging correlates with decreased β -cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for fas and pancreatic duodenal homeobox-1. Diabetes 2006 55 9 2455 2462 2-s2.0-33750577223 10.2337/db05-1586 (Pubitemid 44871145)
14. Nathan D. M., Long-term complications of diabetes mellitus. The New England Journal of Medicine 1993 328 23 1676 1685 2-s2.0-0027253061 10.1056/NEJM199306103282306 (Pubitemid 23157351)
15. Street C. N., Lakey J. R. T., Shapiro A. M. J., Imes S., Rajotte R. V., Ryan E. A., Lyon J. G., Kin T., Avila J., Tsujimura T., Korbutt G. S., Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 2004 53 12 3107 3114 2-s2.0-9444291835 10.2337/diabetes.53.12.3107 (Pubitemid 39564485)
16. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
17. Safdar A., Abadi A., Akhtar M., Hettinga B. P., Tarnopolsky M. A., miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57BI/6J male mice. PLoS ONE 2009 4 5 2-s2.0-66149090410 10.1371/journal.pone. 0005610 e5610
18. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
19. Baek D., Villén J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P., The impact of microRNAs on protein output. Nature 2008 455 7209 64 71 2-s2.0-49949116902 10.1038/nature07242
20. Lynn F. C., Skewes-Cox P., Kosaka Y., McManus M. T., Harfe B. D., German M. S., MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 2007 56 12 2938 2945 2-s2.0-36248978699 10.2337/db07-0175 (Pubitemid 350223628)
21. Joglekar M. V., Joglekar V. M., Hardikar A. A., Expression of islet-specific microRNAs during human pancreatic development. Gene Expression Patterns 2009 9 2 109 113 2-s2.0-58149473947 10.1016/j.gep.2008.10.001
22. Poy M. N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., MacDonald P. E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004 432 7014 226 230 2-s2.0-9144270691 10.1038/nature03076 (Pubitemid 39545853)
23. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R., Diabetes mellitus, a microRNA-related disease? Translational Research 2011 157 4 253 264 2-s2.0-79952795269 10.1016/j.trsl.2011.01.009
24. Lovis P., Gattesco S., Regazzi R., Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biological Chemistry 2008 389 3 305 312 2-s2.0-40149083894 10.1515/BC.2008.026 (Pubitemid 351329024)
25. Baroukh N., Ravier M. A., Loder M. K., Hill E. V., Bounacer A., Scharfmann R., Rutter G. A., Van Obberghen E., MicroRNA-124a regulates foxa2 expression and intracellular signaling in pancreatic β -cell lines. The Journal of Biological Chemistry 2007 282 27 19575 19588 2-s2.0-34547126004 10.1074/jbc.M611841200 (Pubitemid 47100119)
26. Plaisance V., Abderrahmani A., Perret-Menoud V., Jacquemin P., Lemaigre F., Regazzi R., MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. The Journal of Biological Chemistry 2006 281 37 26932 26942 2-s2.0-33748749597 10.1074/jbc.M601225200 (Pubitemid 44401722)
27. Pagliuca F. W., Melton D. A., How to make a functional beta-cell. Development 2013 140 2472 2483 10.1242/dev.093187
28. Bouwens L., Rooman I., Regulation of pancreatic beta-cell mass. Physiological Reviews 2005 85 4 1255 1270 2-s2.0-25444455671 10.1152/physrev.00025.2004 (Pubitemid 41362270)
29. Rukstalis J. M., Habener J. F., Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration. Islets 2009 1 3 177 184 2-s2.0-79953321898
30. Lee C. S., Perreault N., Brestelli J. E., Kaestner K. H., Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes & Development 2002 16 12 1488 1497 2-s2.0-0037097981 10.1101/gad.985002 (Pubitemid 34686330)
31. Apelqvist Å., Li H., Sommer L., Beatus P., Anderson D. J., Honjo T., Hrabě de Angelis M., Lendahl U., Edlund H., Notch signalling controls pancreatic cell differentiation. Nature 1999 400 6747 877 881 2-s2.0-0033606972 10.1038/23716 (Pubitemid 29406724)
32. Winter J., Jung S., Keller S., Gregory R. I., Diederichs S., Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology 2009 11 3 228 234 2-s2.0-61849137222 10.1038/ncb0309-228
33. Joglekar M. V., Parekh V. S., Mehta S., Bhonde R. R., Hardikar A. A., MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Developmental Biology 2007 311 2 603 612 2-s2.0-35848945091 10.1016/j.ydbio.2007.09.008 (Pubitemid 350054939)
34. Lee C. S., de León D. D., Kaestner K. H., Stoffers D. A., Regeneration of pancreatic islets after partial pancreatectomy in mice does not involve the reactivation of neurogenin-3. Diabetes 2006 55 2 269 272 2-s2.0-33644783807 (Pubitemid 43343252)
35. Kaung H.-L. C., Growth dynamics of pancreatic islet cell populations during fetal and neonatal development of the rat. Developmental Dynamics 1994 200 2 163 175 2-s2.0-0028243872 (Pubitemid 24190005)
36. McEvoy R. C., Madson K. L., Pancreatic insulin-, glucagon-, and somatostatin-positive islet cell populations during the perinatal development of the rat. I. Morphometric quantitation. Biology of the Neonate 1980 38 5-6 248 254 2-s2.0-0018909901 (Pubitemid 10001246)
37. McEvoy R. C., Changes in the volumes of the A-, B-, and D-cell populations in the pancreatic islets during the postnatal development of the rat. Diabetes 1981 30 10 813 817 2-s2.0-0019449568 (Pubitemid 11020052)
38. Montanya E., Nacher V., Biarnes M., Soler J., Linear correlation between β -cell mass and body weight throughout the lifespan in Lewis rats: role of β -cell hyperplasia and hypertrophy. Diabetes 2000 49 8 1341 1346 2-s2.0-0033867213 (Pubitemid 30624235)
39. Wang R. N., Bouwens L., Klöppel G., Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia 1996 39 5 548 557 2-s2.0-0029991261 10.1007/s001250050477 (Pubitemid 26135458)
40. Kalis M., Bolmeson C., Esguerra J. L. S., Gupta S., Edlund A., Tormo-Badia N., Speidel D., Holmberg D., Mayans S., Khoo N. K. S., Wendt A., Eliasson L., Cilio C. M., Beta-cell specific deletion of dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS ONE 2011 6 12 2-s2.0-84455161954 10.1371/journal.pone.0029166 e29166
41. Mandelbaum A. D., Melkman-Zehavi T., Oren R., Kredo-Russo S., Nir T., Dor Y., Hornstein E., Dysregulation of Dicer1 in beta cells impairs islet architecture and glucose metabolism. Experimental Diabetes Research 2012 2012 8 470302 10.1155/2012/470302
42. Poy M. N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., Zavolan M., Stoffel M., miR-375 maintains normal pancreatic α-and β -cell mass. Proceedings of the National Academy of Sciences of the United States of America 2009 106 14 5813 5818 2-s2.0-65249093130 10.1073/pnas.0810550106
43. Kloosterman W. P., Lagendijk A. K., Ketting R. F., Moulton J. D., Plasterk R. H. A., Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biology 2007 5 8 e203 2-s2.0-37349055535 10.1371/journal.pbio.0050203 (Pubitemid 47328277)
44. Correa-Medina M., Bravo-Egana V., Rosero S., Ricordi C., Edlund H., Diez J., Pastori R. L., MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expression Patterns 2009 9 4 193 199 2-s2.0-61349122608 10.1016/j.gep.2008.12.003
45. Wang Y., Liu J., Liu C., Naji A., Stoffers D. A., MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta-cells. Diabetes 2013 62 3 887 895 10.2337/db12-0451
46. Rachdi L., Balcazar N., Osorio-Duque F., Elghazi L., Weiss A., Gould A., Chang-Chen K. J., Gambello M. J., Bernal-Mizrachi E., Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 2008 105 27 9250 9255 2-s2.0-48249146208 10.1073/pnas.0803047105
47. Hamada S., Hara K., Hamada T., Yasuda H., Moriyama H., Nakayama R., Nagata M., Yokono K., Upregulation of the mammalian target of rapamycin complex 1 pathway by Ras homolog enriched in brain in pancreatic β -cells leads to increased β -cell mass and prevention of hyperglycemia. Diabetes 2009 58 6 1321 1332 2-s2.0-66649096458 10.2337/db08-0519
48. Xie J., Herbert T. P., The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β -cell mass: implications in the development of type-2 diabetes. Cellular and Molecular Life Sciences 2012 69 8 1289 1304 2-s2.0-80355125578 10.1007/s00018-011-0874-4
49. Parnaud G., Bosco D., Berney T., Pattou F., Kerr-Conte J., Donath M. Y., Bruun C., Mandrup-Poulsen T., Billestrup N., Halban P. A., Proliferation of sorted human and rat beta cells. Diabetologia 2008 51 1 91 100 2-s2.0-36649000083 10.1007/s00125-007-0855-1 (Pubitemid 50002201)
50. Meier J. J., Butler A. E., Saisho Y., Monchamp T., Galasso R., Bhushan A., Rizza R. A., Butler P. C., β -cell replication is the primary mechanism subserving the postnatal expansion of β -cell mass in humans. Diabetes 2008 57 6 1584 1594 2-s2.0-44749088201 10.2337/db07-1369
51. Veld P. I., de Munck N., van Belle K., Buelens N., Ling Z., Weets I., Haentjens P., Pipeleers-Marichal M., Gorus F., Pipeleers D., β -cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 2010 59 7 1702 1708 2-s2.0-77954277549 10.2337/db09-1698
52. Bar Y., Russ H. A., Knoller S., Ouziel-Yahalom L., Efrat S., HES-1 is involved in adaptation of adult human β -cells to proliferation in vitro. Diabetes 2008 57 9 2413 2420 2-s2.0-52749088737 10.2337/db07-1323
53. Rutti S., Sauter N. S., Bouzakri K., Prazak R., Halban P. A., Donath M. Y., In vitro proliferation of adult human beta-cells. PLoS ONE 2012 7 4 2-s2.0-84860363301 10.1371/journal.pone.0035801 e35801
54. Drucker D. J., The biology of incretin hormones. Cell Metabolism 2006 3 3 153 165 2-s2.0-33644618433 10.1016/j.cmet.2006.01.004
55. Hodson D. J., Mitchell R. K., Bellomo E. A., Sun G., Vinet L., Meda P., Li D., Li W. H., Bugliani M., Marchetti P., Bosco D., Piemonti L., Johnson P., Hughes S. J., Rutter G. A., Lipotoxicity disrupts incretin-regulated human beta cell connectivity. The Journal of Clinical Investigation 2013 123 10 4182 4194 10.1172/JCI68459
56. Ferdaoussi M., Abdelli S., Yang J.-Y., Cornu M., Niederhauser G., Favre D., Widmann C., Regazzi R., Thorens B., Waeber G., Abderrahmani A., Exendin-4 protects β -cells from interleukin-1 β -induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 2008 57 5 1205 1215 2-s2.0-48449104756 10.2337/db07-1214
57. Keller D. M., Clark E. A., Goodman R. H., Regulation of microRNA-375 by cAMP in pancreatic beta-cells. Molecular Endocrinology 2012 26 6 989 999 10.1210/me.2011-1205
58. El Ouaamari A., Baroukh N., Martens G. A., Lebrun P., Pipeleers D., van Obberghen E., MiR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β -Cells. Diabetes 2008 57 10 2708 2717 2-s2.0-58149350343 10.2337/db07-1614
59. Krichevsky A. M., Sonntag K.-C., Isacson O., Kosik K. S., Specific MicroRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006 24 4 857 864 2-s2.0-33745480963 10.1634/stemcells.2005-0441 (Pubitemid 44464719)
60. Abderrahmani A., Plaisance V., Lovis P., Regazzi R., Mechanisms controlling the expression of the components of the exocytotic apparatus under physiological and pathological conditions. Biochemical Society Transactions 2006 34 5 696 700 2-s2.0-33751297289 10.1042/BST0340696 (Pubitemid 44796401)
61. Schuit F. C., Veld P. A. I., Pipeleers D. G., Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proceedings of the National Academy of Sciences of the United States of America 1988 85 11 3865 3869 2-s2.0-0039829851
62. Suckale J., Solimena M., Pancreas islets in metabolic signaling-focus on the beta-cell. Frontiers in Bioscience 2008 13 18 7156 7171 2-s2.0-52049103091 10.2741/3198
63. Tang X., Muniappan L., Tang G., Özcan S., Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription. RNA 2009 15 2 287 293 2-s2.0-58249107416 10.1261/rna.1211209
64. Andrali S. S., Smapley M. L., Vanderford N. L., Özcan S., Glucose regulation of insulin gene expression in pancreatic β -cells. Biochemical Journal 2008 415 1 1 10 2-s2.0-53149104775 10.1042/BJ20081029
65. Xu G., Chen J., Jing G., Shalev A., Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nature Medicine 2013 19 1141 1146 10.1038/nm.3287
66. Tweedie E., Artner I., Crawford L., Poffenberger G., Thorens B., Stein R., Powers A. C., Gannon M., Maintenance of hepatic nuclear factor 6 in postnatal islets impairs terminal differentiation and function of β -cells. Diabetes 2006 55 12 3264 3270 2-s2.0-33845524266 10.2337/db06-0090 (Pubitemid 44923582)
67. Rafiq I., da Silva Xavier G., Hooper S., Rutter G. A., Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. The Journal of Biological Chemistry 2000 275 21 15977 15984 2-s2.0-0034717337 10.1074/jbc.275.21.15977 (Pubitemid 30366902)
68. Rhodes C. J., White M. F., Leahy J. L., Kahn S. E., Direct autocrine action of insulin on beta-cells: does it make physiological sense? Diabetes 2013 62 7 2157 2163 10.2337/db13-0246
69. Hashimoto N., Kido Y., Uchida T., Asahara S.-I., Shigeyama Y., Matsuda T., Takeda A., Tsuchihashi D., Nishizawa A., Ogawa W., Fujimoto Y., Okamura H., Arden K. C., Herrera P. L., Noda T., Kasuga M., Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass. Nature Genetics 2006 38 5 589 593 2-s2.0-33646351055 10.1038/ng1774
70. Pullen T. J., Rutter G. A., When less is more: the forbidden fruits of gene repression in the adult beta-cell. Diabetes, Obesity & Metabolism 2013 15 6 503 512 10.1111/dom.12029
71. Pullen T. J., Sylow L., Sun G., Halestrap A. P., Richter E. A., Rutter G. A., Overexpression of monocarboxylate transporter-1 (SLC16A1) in mouse pancreatic beta-cells leads to relative hyperinsulinism during exercise. Diabetes 2012 61 7 1719 1725 10.2337/db11-1531
72. Parsons J. A., Brelje T. C., Sorenson R. L., Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 1992 130 3 1459 1466 2-s2.0-0026573783 10.1210/en.130.3.1459
73. Rieck S., Kaestner K. H., Expansion of β -cell mass in response to pregnancy. Trends in Endocrinology and Metabolism 2010 21 3 151 158 2-s2.0-77949324263 10.1016/j.tem.2009.11.001
74. Jacovetti C., Abderrahmani A., Parnaud G., Jonas J. C., Peyot M. L., Cornu M., Laybutt R., Meugnier E., Rome S., Thorens B., Prentki M., Bosco D., Regazzi R., MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity. The Journal of Clinical Investigation 2012 122 10 3541 3551 10.1172/JCI64151
75. Jacovetti C., Regazzi R., Compensatory beta-cell mass expansion: a big role for a tiny actor. Cell Cycle 2013 12 2 197 198 10.4161/cc.23378
76. Butler A. E., Cao-Minh L., Galasso R., Rizza R. A., Corradin A., Cobelli C., Butler P. C., Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010 53 10 2167 2176 2-s2.0-77958040076 10.1007/s00125-010-1809-6
77. Brubaker P. L., Drucker D. J., Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004 145 6 2653 2659 2-s2.0-2542479899 10.1210/en.2004-0015 (Pubitemid 38686211)
78. Valsamakis G., Margeli A., Vitoratos N., Boutsiadis A., Sakkas E. G., Papadimitriou G., Al-Daghri N. M., Botsis D., Kumar S., Papassotiriou I., Creatsas G., Mastorakos G., The role of maternal gut hormones in normal pregnancy: fasting plasma active glucagon-like peptide 1 level is a negative predictor of fetal abdomen circumference and maternal weight change. European Journal of Endocrinology 2010 162 5 897 903 2-s2.0-77951658373 10.1530/EJE-10-0047
79. Nadal A., Alonso-Magdalena P., Soriano S., Ropero A. B., Quesada I., The role of oestrogens in the adaptation of islets to insulin resistance. The Journal of Physiology 2009 587 21 5031 5037 2-s2.0-70450211212 10.1113/jphysiol.2009.177188
80. Vasavada R. C., Garcia-Ocaña A., Zawalich W. S., Sorenson R. L., Dann P., Syed M., Ogren L., Talamantes F., Stewart A. F., Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. The Journal of Biological Chemistry 2000 275 20 15399 15406 2-s2.0-0034686028 10.1074/jbc.275.20.15399 (Pubitemid 30337270)
81. Weir G. C., Laybutt D. R., Kaneto H., Bonner-Weir S., Sharma A., β -cell adaptation and decompensation during the progression of diabetes. Diabetes 2001 50 supplement 1 S154 S159 2-s2.0-0035130272 (Pubitemid 32148243)
82. Chan J. Y., Luzuriaga J., Bensellam M., Biden T. J., Laybutt D. R., Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in beta-cell gene expression and progression to diabetes. Diabetes 2013 62 5 1557 1568 10.2337/db12-0701
83. Kobayashi K., Forte T. M., Taniguchi S., Ishida B. Y., Oka K., Chan L., The db/db db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 2000 49 1 22 31 2-s2.0-0033956846 10.1016/S0026-0495(00)90588-2 (Pubitemid 30054029)
84. Nesca V., Guay C., Jacovetti C., Menoud V., Peyot M., Laybutt D. R., Prentki M., Regazzi R., Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013 56 10 2203 2212 10.1007/s00125-013-2993-y
85. Locke J. M., da Silva Xavier G., Dawe H. R., Rutter G. A., Harries L. W., Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 2014 57 1 122 128 10.1007/s00125-013-3089-4
86. Boden G., Obesity and free fatty acids. Endocrinology and Metabolism Clinics of North America 2008 37 3 635 646 2-s2.0-50449086746 10.1016/j.ecl.2008.06.007
87. Charles M. A., Eschwège E., Thibult N., Claude J.-R., Warnet J.-M., Rosselin G. E., Girard J., Balkau B., The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris prospective study. Diabetologia 1997 40 9 1101 1106 2-s2.0-0030759095 10.1007/s001250050793 (Pubitemid 27381974)
88. Kjørholt C., Åkerfeldt M. C., Biden T. J., Laybutt D. R., Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of β -cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 2005 54 9 2755 2763 2-s2.0-24144496798 10.2337/diabetes.54.9.2755 (Pubitemid 41233599)
89. Donath M. Y., Schumann D. M., Faulenbach M., Ellingsgaard H., Perren A., Ehses J. A., Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 2008 31 supplement 2 S161 S164 2-s2.0-41149115561
90. Poitout V., Glucolipotoxicity of the pancreatic β -cell: myth or reality? Biochemical Society Transactions 2008 36 5 901 904 2-s2.0-53849106114 10.1042/BST0360901
91. Lovis P., Roggli E., Laybutt D. R., Gattesco S., Yang J.-Y., Widmann C., Abderrahmani A., Regazzi R., Alterations in microRNA expression contribute to fatty acid-induced pancreatic β -Cell dysfunction. Diabetes 2008 57 10 2728 2736 2-s2.0-58149350340 10.2337/db07-1252
92. Eguchi K., Manabe I., Oishi-Tanaka Y., Ohsugi M., Kono N., Ogata F., Yagi N., Ohto U., Kimoto M., Miyake K., Tobe K., Arai H., Kadowaki T., Nagai R., Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metabolism 2012 15 4 518 533 2-s2.0-84859449180 10.1016/j.cmet.2012.01.023
93. Roggli E., Britan A., Gattesco S., Lin-Marq N., Abderrahmani A., Meda P., Regazzi R., Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β -cells. Diabetes 2010 59 4 978 986 2-s2.0-77951158889 10.2337/db09-0881
94. Abderrahmani A., Niederhauser G., Favre D., Abdelli S., Ferdaoussi M., Yang J. Y., Regazzi R., Widmann C., Waeber G., Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 2007 50 6 1304 1314 2-s2.0-34247866358 10.1007/s00125-007-0642-z (Pubitemid 46701553)
95. Favre D., Niederhauser G., Fahmi D., Plaisance V., Brajkovic S., Beeler N., Allagnat F., Haefliger J. A., Regazzi R., Waeber G., Abderrahmani A., Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets. Diabetologia 2011 54 9 2337 2346 2-s2.0-80054707772 10.1007/s00125-011-2165-x
96. Haefliger J. A., Martin D., Favre D., Petremand Y., Mazzolai L., Abderrahmani A., Meda P., Waeber G., Allagnat F., Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles. PloS ONE 2013 8 1 e55198 10.1371/journal.pone.0055198
97. Holvoet P., Kritchevsky S. B., Tracy R. P., Mertens A., Rubin S. M., Butler J., Goodpaster B., Harriss T. B., The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004 53 4 1068 1073 2-s2.0-1842527452 10.2337/diabetes.53.4.1068 (Pubitemid 38436620)
98. Nakhjavani M., Khalilzadeh O., Khajeali L., Esteghamati A., Morteza A., Jamali A., Dadkhahipour S., Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids 2010 45 4 321 327 2-s2.0-77953289382 10.1007/s11745-010-3401-8
99. Bellomo G., Maggi E., Poli M., Agosta F. G., Bollati P., Finardi G., Antoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 1995 44 1 60 66 2-s2.0-0028985195
100. Brunham L. R., Kruit J. K., Verchere C. B., Hayden M. R., Cholesterol in islet dysfunction and type 2 diabetes. The Journal of Clinical Investigation 2008 118 2 403 408 2-s2.0-38849201796 10.1172/JCI33296 (Pubitemid 351206525)
101. Drew B. G., Duffy S. J., Formosa M. F., Natoli A. K., Henstridge D. C., Penfold S. A., Thomas W. G., Mukhamedova N., de Courten B., Forbes J. M., Yap F. Y., Kaye D. M., ven Hall G., Febbraio M. A., Kemp B. E., Sviridov D., Steinberg G. R., Kingwell B. A., High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 2009 119 15 2103 2111 2-s2.0-65449178091 10.1161/CIRCULATIONAHA.108.843219
102. Okajima F., Kurihara M., Ono C., Nakajima Y., Tanimura K., Sugihara H., Tatsuguchi A., Nakagawa K., Miyazawa T., Oikawa S., Oxidized but not acetylated low-density lipoprotein reduces preproinsulin mRNA expression and secretion of insulin from HIT-T15 cells. Biochimica et Biophysica Acta 2005 1687 1-3 173 180 2-s2.0-13644252970 10.1016/j.bbalip.2004.11.018 (Pubitemid 40228997)
103. Rütti S., Ehses J. A., Sibler R. A., Prazak R., Rohrer L., Georgopoulos S., Meier D. T., Niclauss N., Thierry B., Donath M. Y., von Eckardstein A., Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic β -cells. Endocrinology 2009 150 10 4521 4530 2-s2.0-70349320177 10.1210/en.2009-0252
104. Roehrich M.-E., Mooser V., Lenain V., Herz J., Nimpf J., Azhar S., Bideau M., Capponi A., Nicod P., Haefliger J.-A., Waeber G., Insulin-secreting β -cell dysfunction induced by human lipoproteins. The Journal of Biological Chemistry 2003 278 20 18368 18375 2-s2.0-0038381515 10.1074/jbc.M300102200 (Pubitemid 36799458)
105. Bonnefond A., Froguel P., Vaxillaire M., The emerging genetics of type 2 diabetes. Trends in Molecular Medicine 2010 16 9 407 416 2-s2.0-77956266047 10.1016/j.molmed.2010.06.004
106. Vaxillaire M., Abderrahmani A., Boutin P., Bailleul B., Froguel P., Yaniv M., Pontoglio M., Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. The Journal of Biological Chemistry 1999 274 50 35639 35646 2-s2.0-0033544962 10.1074/jbc.274.50.35639 (Pubitemid 129512863)
107. Bonner C., Nyhan K. C., Bacon S., Kyithar M. P., Schmid J., Concannon C. G., Bray I. M., Stallings R. L., Prehn J. H., Byrne M. M., Identification of circulating microRNAs in HNF1A-MODY carriers. Diabetologia 2013 56 8 1743 1751 10.1007/s00125-013-2939-4
108. Wang H., Antinozzi P. A., Hagenfeldt K. A., Maechler P., Wollheim C. B., Molecular targets of a human HNF1 α mutation responsible for pancreatic β -cell dysfunction. The EMBO Journal 2000 19 16 4257 4264 2-s2.0-0034663750 (Pubitemid 30623736)
109. Guay C., Jacovetti C., Nesca V., Motterle A., Tugay K., Regazzi R., Emerging roles of non-coding RNAs in pancreatic beta-cell function and dysfunction. Diabetes, Obesity & Metabolism 2012 14 supplement 3 12 21 10.1111/j.1463-1326.2012.01654.x
110. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M., Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research 2010 107 6 810 817 2-s2.0-77957259803 10.1161/CIRCRESAHA.110.226357
111. Moran I., Akerman I., van de Bunt M., Xie R., Benazra M., Nammo T., Arnes L., Nakić N., García-Hurtado J., Rodríguez-Seguí S., Pasquali L., Sauty-Colace C., Beucher A., Scharfmann R., Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metabolism 2012 16 4 435 448 10.1016/j.cmet.2012.08.010
112. Wahlestedt C., Targeting long non-coding RNA to therapeutically upregulate gene expression. Nature Reviews Drug Discovery 2013 12 433 446 10.1038/nrd4018
113. Lee J. T., Bartolomei M. S., X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 2013 152 6 1308 1323 10.1016/j.cell.2013.02.016
114. Batista P. J., Chang H. Y., Long noncoding RNAs: cellular address codes in development and disease. Cell 2013 152 6 1298 1307 10.1016/j.cell.2013.02.012